Cargando…

Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases

Objective: The easy liver fibrosis test (eLIFT) is a novel predictor of liver fibrosis in chronic liver disease (CLD). This study aimed to evaluate the predictive value of the eLIFT for liver inflammation and fibrosis in CLD patients. Methods: We enrolled 1125 patients with CLD who underwent liver b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zongguo, Ma, Xin, Zhou, Xinlan, Huang, Dan, Wang, Yanbing, Li, Xiufen, Lu, Wei, Zhang, Zhanqing, Ding, Rongrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436088/ https://www.ncbi.nlm.nih.gov/pubmed/34522187 http://dx.doi.org/10.7150/ijms.62386

Ejemplares similares

Predictive Performances of Blood Parameter Ratios for Liver Inflammation and Advanced Liver Fibrosis in Chronic Hepatitis B Infection
por: Ding, Rongrong, et al.
Publicado: (2021)

Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease
por: Ding, Rongrong, et al.
Publicado: (2021)

INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection
por: Li, Qiang, et al.
Publicado: (2017)

A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19
por: Ding, Rongrong, et al.
Publicado: (2021)

eLift, Helium Plasma Radiofrequency (Renuvion) Subdermal Treatment and Minimal Access Face and Neck Lift, is an Effective Facial Rejuvenation Technique with Minimal Downtime
por: Hoang, Han
Publicado: (2023)

Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection
por: Zhang, Zhanqing, et al.
Publicado: (2022)

DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway
por: Ding, Rongrong, et al.
Publicado: (2021)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Necroptosis contributes to chronic inflammation and fibrosis in aging liver
por: Mohammed, Sabira, et al.
Publicado: (2021)

A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis
por: Fransén-Pettersson, Nina, et al.
Publicado: (2016)

Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2021)

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study
por: Chen, Tianyou, et al.
Publicado: (2021)

Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats
por: Chen, Xiaorong, et al.
Publicado: (2012)

A Bioinformatic Analysis of Correlations between Polymeric Immunoglobulin Receptor (PIGR) and Liver Fibrosis Progression
por: Zhang, Yuan, et al.
Publicado: (2021)

Liver regeneration and fibrosis after inflammation
por: Tanaka, Minoru, et al.
Publicado: (2016)

MAIT cells in liver inflammation and fibrosis
por: Mehta, Hema, et al.
Publicado: (2022)

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021)

Functions of Liver Natural Killer Cells Are Dependent on the Severity of Liver Inflammation and Fibrosis in Chronic Hepatitis C
por: Fugier, Emilie, et al.
Publicado: (2014)

Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
por: Tanwar, Sudeep, et al.
Publicado: (2020)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
por: Dai, Yi-Ning, et al.
Publicado: (2023)

Current ultrasound-related strategies for assessing liver fibrosis in chronic liver disease
por: Xue, Li-Yun, et al.
Publicado: (2020)

Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production
por: Wang, Huafeng, et al.
Publicado: (2016)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Correction to: MAIT cells in liver inflammation and fibrosis
por: Mehta, Hema, et al.
Publicado: (2022)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

Calcipotriol attenuates liver fibrosis through the inhibition of vitamin D receptor-mediated NF-κB signaling pathway
por: Gong, Jian, et al.
Publicado: (2022)

The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
por: Xu, Jun, et al.
Publicado: (2017)

Enzymes of Fibrosis in Chronic Liver Disease
por: Tsomidis, Ioannis, et al.
Publicado: (2022)

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
por: Zeremski, Marija, et al.
Publicado: (2014)

Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease
por: To, Keii, et al.
Publicado: (2023)

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
por: Graupera, Isabel, et al.
Publicado: (2022)

The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis
por: Xie, Qingsong, et al.
Publicado: (2014)

TRIF as a Novel Modulator of Liver Inflammation and Fibrosis
por: Török, Natalie J.
Publicado: (2017)

Liver Fibrosis and Inflammation under the Control of ERK2
por: Jeng, Kuo-Shyang, et al.
Publicado: (2020)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
por: Sonneveld, Milan J., et al.
Publicado: (2020)

Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo
por: Tacke, Frank
Publicado: (2012)

Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
por: Liu, Cheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qqlo6h381jqbk1n5e5ukplq3jn